Dr. Duncan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
# WRN825
Boston, MA 02114Phone+1 617-726-5209Fax+1 617-643-1624
Education & Training
Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Dermatopathology, 1990 - 1991
Washington University/B-JH/SLCH ConsortiumResidency, Pathology-Anatomic and Clinical, 1986 - 1990- Washington University in St. Louis School of MedicineClass of 1986
Certifications & Licensure
MA State Medical License 1991 - 2026
NY State Medical License 2012 - 2026
ME State Medical License 2016 - 2025
MO State Medical License 1990 - 2025
VT State Medical License 2013 - 2024
GA State Medical License 2013 - 2021- American Board of Pathology Anatomic Pathology
- American Board of Pathology Dermatopathology
Publications & Presentations
PubMed
- 11 citationsAppropriate use criteria for ancillary diagnostic testing in dermatopathology: New recommendations for 11 tests and 220 clinical scenarios from the American Society of...Maxwell A Fung, Claudia I. Vidal, Eric A Armbrecht, Aleodor A. Andea, David S. Cassarino
Journal of Cutaneous Pathology. 2021-09-18 - 16 citationsImpact of Next-generation Sequencing on Interobserver Agreement and Diagnosis of Spitzoid Neoplasms.Sarah Benton, Jeffrey Zhao, Bin Zhang, Armita Bahrami, Raymond L. Barnhill
The American Journal of Surgical Pathology. 2021-12-01 - 72 citationsConstitutive Aberrant Endogenous Interleukin-1 Facilitates Inflammation and Growth in Human MelanomaYong Qin, Suhendan Ekmekcioglu, Ping Liu, Lyn M. Duncan, Gregory Lizée
Molecular Cancer Research. 2011-11-01
Lectures
- Dermatopathology UpdateHarvard Medical School ,Department Of Continuing Education, Boston, Massachusetts - 9/19/2013
- Dermatopathology Update With Mini-Symposiums on Inflammatory Dermatoses and New Diagnostic Testings for Melanocytic LesionsHarvard Medical School, Boston, Massachusetts - 9/20/2012
Press Mentions
Loss of GCNT2/I-branched Glycans Enhances Melanoma Growth and SurvivalAugust 22nd, 2018
Professional Memberships
- Fellow
- Fellow
- American Society of DermatopathologyPresident
- International Society of DermatopathologyMember
- International Melanoma Study GroupMember
- Society for Melanoma ResearchMember
- United States Cutaneous Lymphoma ConsortiumMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
